3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
5
Thoracic
1
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Endocrine
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Leukemia, Myeloid, Acute
437
Precursor Cell Lymphoblastic Leukemia-Lymphoma
237
Hematologic Neoplasms
215
Leukemia, Lymphocytic, Chronic, B-Cell
189
Myelodysplastic Syndromes
160
Leukemia
129
Lymphoma
93
Lymphoma, Non-Hodgkin
79
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
71
Multiple Myeloma
69
Recurrence
60
Leukemia, Myelomonocytic, Chronic
56
Neoplasms
52
Leukemia, Biphenotypic, Acute
49
Burkitt Lymphoma
46
Myeloproliferative Disorders
44
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
43
Lymphoma, Mantle-Cell
41
Lymphoma, Large B-Cell, Diffuse
41
Hodgkin Disease
37
Lymphoma, Follicular
33
Lymphoma, B-Cell
32
Lymphoma, B-Cell, Marginal Zone
27
Waldenstrom Macroglobulinemia
26
Leukemia, B-Cell
26
Anemia, Refractory, with Excess of Blasts
25
Primary Myelofibrosis
22
Leukemia, Myeloid, Chronic-Phase
20
Myelodysplastic-Myeloproliferative Diseases
19
Hematologic Diseases
18
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Duodenal Neoplasms
×
Other hematologic neoplasm
×
90 days
×
Clear all
NCT02012699
2026-05-05
iCaRe2
University of Nebraska
Recruiting
999,999 enrolled